Detalles de la búsqueda
1.
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
Cancer
; 128(8): 1595-1604, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157306
2.
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.
Blood
; 133(19): 2031-2042, 2019 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30842083
3.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31568564
4.
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.
Blood
; 129(19): 2612-2615, 2017 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373262
5.
Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis.
Am J Hematol
; 94(5): 554-562, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30767298
6.
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Am J Hematol
; 94(12): 1353-1363, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31512258
7.
Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab.
J Oncol Pharm Pract
; 25(3): 706-709, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29334337
8.
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 23(11): 1826-1838, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28797780
9.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
N Engl J Med
; 371(3): 213-23, 2014 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24881631
10.
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Mod Pathol
; 30(12): 1688-1697, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28776574
11.
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.
Am J Hematol
; 92(2): 161-170, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27880984
12.
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 22(12): 2117-2125, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27660167
13.
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Br J Haematol
; 175(4): 631-640, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27469075
14.
CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma.
Eur J Haematol
; 97(1): 39-47, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26340843
15.
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(6): 971-83, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773017
16.
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Biol Blood Marrow Transplant
; 20(7): 951-9, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24641828
17.
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 20(11): 1729-36, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25008330
18.
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.
Oncologist
; 19(6): 616-22, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24797823
19.
Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.
Br J Haematol
; 179(4): 674-676, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27409578
20.
Beyond Epstein-Barr virus: genetic predisposition of natural killer T-cell lymphoma.
Lancet Oncol
; 17(9): 1176-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27470080